H.R. 9559 · 117th Congress
Innovative Technologies Impacted by COVID–19 Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
SchneiderSponsor4 cosponsors · 2 D, 2 R
4 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.
What it does: CRS summary · Introduced in House · Dec 14, 2022
Innovative Technologies Impacted by COVID-19 Act
This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Innovative Technologies Impacted by COVID–19 Act
Latest action (Dec 14, 2022): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Policy area: Health · Origin: House · Introduced: Dec 14, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.